Lataa...
Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib
MET receptor tyrosine kinase and its natural ligand, hepatocyte growth factor, have been implicated in a variety of cancers, including non-small cell lung cancer (NSCLC). Mechanisms by which cellular deregulation of MET occurs include overexpression, genomic amplification, mutation, or alternative s...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4198276/ https://ncbi.nlm.nih.gov/pubmed/25328417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S37345 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|